D7L2 (AngaD7L2) is a long-form salivary protein from female Anopheles gambiae mosquitoes that facilitates blood feeding through anticoagulant activity. Unlike the short-form D7 proteins (D7r1-r4) which primarily bind biogenic amines, D7L2 functions primarily by targeting the intrinsic coagulation pathway - it binds coagulation factors XII (both inactive and activated FXIIa) and XI (inactive), preventing generation of activated FXIIa and FXIa. D7L2 also weakly binds leukotrienes B4 and D4, though this binding is less pronounced than in the related D7L1 protein. The protein belongs to the PBP/GOBP structural family but has evolved a distinct function unrelated to olfaction.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0035821
modulation of process of another organism
|
IEA
GO_REF:0000108 |
ACCEPT |
Summary: This annotation correctly describes D7L2's function. The protein modulates host hemostatic responses during blood feeding by binding coagulation factors XII and XI and preventing their activation, as well as weakly sequestering leukotrienes. This is a valid BP annotation for the cross-species effect.
Reason: D7L2 clearly modulates processes in the vertebrate host. Per UniProt, it "Modulates blood feeding of female mosquitoes on vertebrate species by binding and sequestering different mediators involved in the host response" and "Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa" [UniProt A0A1S4GYJ6]. The GO:0035821 definition "A process in which an organism effects a change in a biological process in another organism" accurately captures this function. PMID:35460690 demonstrates anticoagulant activity through binding host coagulation factors. The annotation was inferred via GO_REF:0000108 from the toxin activity annotation, but the underlying logic is sound for this BP term - binding host coagulation factors does modulate host hemostatic processes.
Supporting Evidence:
UniProt:A0A1S4GYJ6
Modulates blood feeding of female mosquitoes on vertebrate species by binding and sequestering different mediators involved in the host response
UniProt:A0A1S4GYJ6
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
|
|
GO:0005549
odorant binding
|
IEA
GO_REF:0000002 |
REMOVE |
Summary: This annotation is INCORRECT. It is based solely on structural family membership (PBP/GOBP family via InterPro IPR006170) but does not reflect the actual function of D7L2. The protein binds coagulation factors and weakly binds leukotrienes, not odorants, and has no role in olfaction. D7L2 is expressed in salivary glands, not olfactory tissues.
Reason: D7L2 belongs to the PBP/GOBP structural family (InterPro IPR006170), which led to this IEA annotation via GO_REF:0000002. However, D7 proteins have evolutionarily repurposed this fold for binding host hemostatic/inflammatory mediators in saliva, not odorants in antennae. D7L2 is secreted from female salivary glands during blood feeding [UniProt A0A1S4GYJ6]. The actual molecular functions involve binding coagulation factors XII and XI [PMID:35460690, UniProt A0A1S4GYJ6] and weakly binding leukotrienes B4 and D4 [PMID:35460690, UniProt A0A1S4GYJ6]. The GO:0005549 definition "Binding to an odorant, any substance capable of stimulating the sense of smell" is completely inappropriate - coagulation factors and leukotrienes are not odorants. This is a clear case where structural homology does not predict function. Deep research on the D7 family confirms long-form D7s "bind lipid mediators (cysteinyl leukotrienes; some bind thromboxane A2 analogs) via their N-terminal domain" [file:ANOGA/D7r1/D7r1-deep-research-falcon.md], not odorants.
Supporting Evidence:
UniProt:A0A1S4GYJ6
Binds leukotriene B4 and leukotriene D4 (PubMed:35460690). Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa (PubMed:35460690).
UniProt:A0A1S4GYJ6
SUBCELLULAR LOCATION: Secreted
file:ANOGA/D7r1/D7r1-deep-research-falcon.md
long-form D7s bind lipid mediators (cysteinyl leukotrienes; some bind thromboxane A2 analogs) via their N-terminal domain; the biogenic-amine binding role present in the C-terminal domain of some Aedes long forms appears to be assumed by Anopheles short forms
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: This annotation correctly reflects the subcellular localization of D7L2 as a secreted salivary protein.
Reason: D7L2 is a secreted protein with a signal peptide (residues 1-18) [UniProt A0A1S4GYJ6]. It is released into the extracellular space (saliva) during blood feeding. The UniProt entry confirms "SUBCELLULAR LOCATION: Secreted" [UniProt A0A1S4GYJ6]. This is an appropriate CC annotation. D7L2 functions at the host bite site, which is an extracellular location. Deep research on the D7 family confirms salivary D7 proteins are "produced in adult female salivary glands and secreted in saliva at the skin interface during probing/feeding" [file:ANOGA/D7r1/D7r1-deep-research-falcon.md].
Supporting Evidence:
UniProt:A0A1S4GYJ6
SUBCELLULAR LOCATION: Secreted
file:ANOGA/D7r1/D7r1-deep-research-falcon.md
D7r1 is produced in adult female salivary glands and secreted in saliva at the skin interface during probing/feeding
|
|
GO:0090729
toxin activity
|
IEA
GO_REF:0000043 |
MARK AS OVER ANNOTATED |
Summary: This annotation is an OVER-ANNOTATION. D7L2 does not meet the GO definition of toxin activity, which requires "initiating pathogenesis (leading to an abnormal, generally detrimental state)". D7L2 transiently modulates host coagulation by binding coagulation factors, but does not cause disease or tissue damage. The weak leukotriene binding also does not constitute toxin activity.
Reason: The GO:0090729 definition states: "Interacting selectively with one or more biological molecules in another (target) organism, initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target organism." D7L2 does NOT meet this definition because: (1) It does not initiate pathogenesis - it facilitates feeding, not disease; (2) It does not cause tissue damage - it transiently binds coagulation factors and weakly sequesters leukotrienes; (3) The effect is reversible and temporary; (4) The host returns to normal state after feeding. The UniProt keywords "Blood coagulation cascade inhibiting toxin" and "Hemostasis impairing toxin" that led to this IEA annotation via GO_REF:0000043 are technically inaccurate - anti-hemostatic activity via protein binding is fundamentally different from true toxin activity that causes pathological damage. D7L2's mechanism of binding coagulation factors XII and XI to prevent their activation [PMID:35460690] is a reversible protein-protein interaction, not toxic pathogenesis. Deep research on D7 proteins explicitly describes the mechanism as kratagonism (scavenging host mediators), not toxicity [file:ANOGA/D7r1/D7r1-deep-research-falcon.md].
Supporting Evidence:
UniProt:A0A1S4GYJ6
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
file:ANOGA/D7r1/D7r1-deep-research-falcon.md
D7 proteins are among the most abundant mosquito salivary proteins and function as kratagonists - high-affinity scavengers of host small-molecule inflammatory and hemostatic mediators
|
|
GO:0030195
negative regulation of blood coagulation
|
IDA
PMID:35460690 Novel salivary antihemostatic activities of long-form D7 pro... |
NEW |
Summary: D7L2 exhibits anticoagulant activity by binding coagulation factors XII and XI and preventing their activation. This is a well-supported biological process annotation based on experimental evidence from PMID:35460690.
Reason: UniProt states D7L2 "Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa (PubMed:35460690)" [UniProt A0A1S4GYJ6]. PMID:35460690 demonstrates that "AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway". GO:0030195 definition "Any process that stops, prevents, or reduces the frequency, rate or extent of blood coagulation" accurately describes this function. This is a more accurate BP annotation than inferring from "toxin activity".
Supporting Evidence:
UniProt:A0A1S4GYJ6
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
|
|
GO:0005515
protein binding
|
IPI
PMID:35460690 Novel salivary antihemostatic activities of long-form D7 pro... |
NEW |
Summary: D7L2 binds host coagulation factors XII (both inactive and activated FXIIa) and XI (inactive). While GO:0005515 is a general term, it accurately describes the molecular function. This binding underlies D7L2's anticoagulant activity.
Reason: UniProt confirms D7L2 "Interacts with host coagulation factor XII/F12 (inactive and activated) (PubMed:35460690). Interacts with host coagulation factor XI/F11 (inactive) (PubMed:35460690)" [UniProt A0A1S4GYJ6]. While GO:0005515 is a general MF term, it is appropriate here because D7L2 binds coagulation factors to prevent their activation - this is a protein-protein interaction that underlies the anticoagulant activity. There is no more specific GO term for "coagulation factor binding".
Supporting Evidence:
UniProt:A0A1S4GYJ6
Interacts with host coagulation factor XII/F12 (inactive and activated) (PubMed:35460690)
UniProt:A0A1S4GYJ6
Interacts with host coagulation factor XI/F11 (inactive) (PubMed:35460690)
|
Q: What are the binding affinities (Kd values) of D7L2 for coagulation factors XII and XI compared to D7L1? The paper mentions SPR kinetic analysis was performed.
Suggested experts: Calvo E, Ribeiro JM
Q: Is the weak leukotriene binding by D7L2 biologically significant, or is D7L1 the primary leukotriene scavenger among the Anopheles long-form D7 proteins?
Suggested experts: Calvo E, Andersen JF
Q: Does D7L2 have any biogenic amine binding activity like the short-form D7 proteins, or is this function completely absent in Anopheles long-form D7s?
Suggested experts: Mans BJ, Calvo E
Experiment: Generate individual D7L1 and D7L2 knockout A. gambiae using CRISPR and compare blood feeding efficiency, clotting time at bite site, and inflammatory responses to determine the distinct contributions of each long-form D7 protein
Hypothesis: D7L2 knockout mosquitoes will have reduced blood feeding efficiency specifically due to host coagulation responses, while D7L1 knockout effects would be more related to leukotriene-mediated inflammation
Type: Gene knockout and comparative feeding assay
Experiment: Perform structural studies (X-ray crystallography or cryo-EM) of D7L2 in complex with FXII and FXIIa to determine the binding interface and mechanism of inhibition
Hypothesis: D7L2 binding to FXII prevents its conformational change required for autoactivation
Type: Structural biology
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-30T08:21:34.254917'
end_time: '2026-01-30T08:30:00.923774'
duration_seconds: 506.67
template_file: templates/gene_research_go_focused.md
template_variables:
organism: ANOGA
gene_id: D7L2
gene_symbol: D7L2
uniprot_accession: A0A1S4GYJ6
protein_description: 'RecName: Full=Long form salivary protein D7L2 {ECO:0000305};
Short=AngaD7L2 {ECO:0000303|PubMed:35460690}; Flags: Precursor;'
gene_info: Name=D7L2 {ECO:0000305};
organism_full: Anopheles gambiae (African malaria mosquito).
protein_family: Belongs to the PBP/GOBP family. .
protein_domains: PBP/GOBP. (IPR006170); PBP_GOBP_sf. (IPR036728); PBP_GOBP (PF01395)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 21
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'D7L2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene D7L2 (gene ID: D7L2, UniProt: A0A1S4GYJ6) in ANOGA.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'D7L2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene D7L2 (gene ID: D7L2, UniProt: A0A1S4GYJ6) in ANOGA.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Title: Functional annotation of Anopheles gambiae D7L2 (AngaD7L2; UniProt A0A1S4GYJ6)
Executive summary
D7L2 is a female salivary-gland secreted, long-form member of the D7 family in Anopheles gambiae, distantly related to the odorant-binding protein (PBP/GOBP) superfamily. It functions as a kratagonist that binds host hemostatic and inflammatory mediators, facilitating blood feeding by suppressing vasoconstriction, platelet aggregation, and local inflammation. Evidence from RNAi knockdown demonstrates D7L2 is required for efficient probing/blood feeding, while human serology indicates strong immunogenicity with utility as an exposure biomarker. Recent 2024 studies highlight regulatory variation and expression changes in D7 genes associated with insecticide resistance contexts.
1) Key concepts and definitions
- Identity and family: D7L2 (AngaD7L2) is a long-form D7 salivary protein of An. gambiae; D7 proteins are OBP/PBP-related, abundant salivary secreted proteins in blood-feeding Diptera that act as kratagonists of host mediators (biogenic amines and eicosanoids) at the bite site (family/domain context and structural fold) (martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9).
- Long vs short D7 forms: Long forms are two-domain proteins with an N-terminal eicosanoid-binding pocket and a C-terminal biogenic-amine pocket (functional diversification within the family) (martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9).
- AngaD7L2 role in feeding: Silencing D7L2 increases probing time and reduces blood-feeding success, directly implicating it in counteracting host hemostasis (das2010transcriptomicandfunctional pages 9-11).
2) Molecular function and ligand specificity (current understanding)
- Direct functional evidence in An. gambiae: RNAi of D7L2 causes significant probing time increase (p=0.002), supporting an anti-hemostatic role in vivo (das2010transcriptomicandfunctional pages 9-11).
- Biochemical mechanism inferred from anopheline D7 long forms: Anopheles long-form D7 proteins bind eicosanoids including thromboxane A2 analogs and cysteinyl leukotrienes via a conserved N‑terminal pocket, inhibiting platelet activation and inflammation; structural/functional characterization in anopheline D7s supports this mechanism (jablonka2019functionalandstructural pages 7-9, martinmartin2020adpbindingby pages 1-2).
- Comparative specificity from closely related species: Ae. aegypti D7L2 binds the TXA2 analog U‑46619 and modulates vasoconstriction/platelet aggregation; Culex D7 long forms further illustrate family diversity (e.g., ADP-binding), emphasizing species-specific ligand profiles. These data support, but do not overclaim, that AngaD7L2 likely targets eicosanoids/biogenic amines consistent with long-form D7s (martin‐martin2021biochemicalcharacterizationof pages 1-2, martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9).
3) Structural features and domain architecture
- D7 fold and OBP ancestry: The D7 fold comprises an array of α‑helices stabilized by disulfide bonds, characteristic of OBP-related proteins; structures of An. gambiae D7r4 (short-form) and sand fly long-form D7-like proteins illustrate the conserved architecture and binding pocket topology (jablonka2019functionalandstructural pages 7-9).
- Long-form modularity: Long D7s consist of N- and C-terminal domains with distinct ligand pockets; the N-terminal pocket accommodates leukotrienes/TXA2 analogs, while the C-terminal pocket often binds biogenic amines, though some long forms lack amine binding (jablonka2019functionalandstructural pages 7-9, martinmartin2020adpbindingby pages 1-2).
4) Localization and secretion
- Tissue specificity: D7 proteins, including D7L2, are abundantly expressed in female salivary glands and secreted into saliva that is injected during probing. D7L2 transcript abundance decreases after blood feeding, consistent with utilization or early downregulation (das2010transcriptomicandfunctional pages 9-11, oseno2022characterizationofanopheles pages 1-2).
5) Physiological/pathway role
- Anti-hemostatic and anti-inflammatory activity: By sequestering host mediators (biogenic amines, leukotrienes/TXA2 analogs), the D7 family inhibits vasoconstriction and platelet aggregation and dampens local inflammation, thereby facilitating blood meal acquisition (martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9). RNAi phenotypes of D7L2 in An. gambiae validate this function in vivo (das2010transcriptomicandfunctional pages 9-11).
- Infection context: Long-form D7 is overexpressed in salivary glands of An. gambiae infected with wild Plasmodium falciparum, suggesting parasite-modulated expression and potential to mark infective bites (marie2014anophelesgambiaesalivary pages 7-9).
6) Expression regulation and links to insecticide resistance (recent developments 2023–2024)
- Insecticide resistance association (ortholog evidence): In An. arabiensis from Western Kenya, RNA‑seq revealed overexpression of salivary D7 long/short genes, including D7L1/D7L2, in survivors exposed to pyrethroids and organophosphates, suggesting co-regulation or pleiotropic expression shifts in resistant populations (oseno2022characterizationofanopheles pages 1-2).
- Cis-regulatory variation in An. gambiae: Allele-specific expression analyses identified D7L2 among genes showing ASE in crosses of resistant and susceptible strains, indicating cis‑regulatory elements contribute to D7 expression differences (oseno2022characterizationofanopheles pages 1-2).
7) Current applications and real-world implementations
- Serological biomarkers of exposure: Recombinant D7L2 elicits strong human IgG responses that reflect transmission intensity and are lower among bednet users, supporting use as a quantitative biomarker to monitor human–vector contact and intervention impact (oseno2022characterizationofanopheles pages 1-2).
- Candidate markers of infective bites: Proteomic evidence that long-form D7 is upregulated in P. falciparum–infected salivary glands and the identification of antigenic peptides support development of peptide assays to indicate exposure to potentially infective bites (marie2014anophelesgambiaesalivary pages 7-9).
8) Expert opinions and synthesis from authoritative sources
- Structural/functional consensus: Long-form D7 proteins across Diptera are convergently adapted kratagonists that target eicosanoids and, variably, biogenic amines; conservation of the N‑terminal eicosanoid pocket underpins anti-platelet/anti-inflammatory function, with notable species-specific diversification underscoring the need for species-specific biochemical validation (jablonka2019functionalandstructural pages 7-9, martinmartin2020adpbindingby pages 1-2).
9) Relevant statistics and quantitative data
- Functional phenotype: D7L2 RNAi knockdown in An. gambiae significantly increased probing time (p=0.002), indicating impaired feeding efficiency (das2010transcriptomicandfunctional pages 9-11).
- Serology: In human cohorts, anti‑D7L2 IgG levels increased with age and were significantly lower in bednet users versus non-users, aligning with differential exposure; responses tracked transmission intensity across sites (oseno2022characterizationofanopheles pages 1-2).
10) Limitations and open questions
- Ligand specificity of AngaD7L2: While long-form D7s in Anopheles bind eicosanoids and some biogenic amines, direct biochemical binding data for AngaD7L2 in An. gambiae remain to be reported; cross-species extrapolation should be treated cautiously given demonstrated diversification in D7 ligand preferences (martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9).
11) Verified identity and ambiguity check
- The gene symbol D7L2 matches the UniProt-described long-form salivary protein (AngaD7L2) from Anopheles gambiae and belongs to the OBP/PBP-related D7 family. No conflicting gene with the same symbol in other organisms is cited here; all evidence pertains to anopheline salivary D7 proteins (martinmartin2020adpbindingby pages 1-2, jablonka2019functionalandstructural pages 7-9, das2010transcriptomicandfunctional pages 9-11).
Evidence table
| Source (first author, year, journal, URL) | Organism / protein | Key finding(s) | Assay / type | Relevance to D7L2 |
|---|---|---|---|---|
| Das 2010, BMC Genomics (https://doi.org/10.1186/1471-2164-11-566) (das2010transcriptomicandfunctional pages 9-11) | Anopheles gambiae — D7L2 | RNAi silencing of D7L2 increased probing time and reduced blood-feeding, supporting an anti‑hemostatic role | RNAi knockdown in adult females; feeding/probing behavioral assays | Direct loss-of-function evidence that D7L2 facilitates blood feeding |
| Oseno 2022, Parasites & Vectors (https://doi.org/10.1186/s13071-021-05130-5) (oseno2022characterizationofanopheles pages 1-2) | Anopheles gambiae — recombinant D7L2 | Human IgG responses to D7L2 correlate with exposure and are lower in bednet users; candidate exposure biomarker | Recombinant antigen ELISA serology in human cohorts | Epidemiological application: D7L2 as serological marker of human–vector contact and vector-control impact |
| Marie 2014, Parasites & Vectors (https://doi.org/10.1186/s13071-014-0599-y) (marie2014anophelesgambiaesalivary pages 7-9) | Anopheles gambiae — long-form D7 | Long-form D7 overexpressed in P. falciparum–infected salivary glands; antigenic peptides identified | Proteomics (2D-DIGE, MS) and epitope mapping with human sera | Suggests parasite-modulated expression and potential markers of infective bites |
| Jablonka 2019, Scientific Reports (https://doi.org/10.1038/s41598-019-41848-0) (jablonka2019functionalandstructural pages 7-9) | Mosquito & sand fly long-form D7 (comparative) | Structural conservation of N-terminal eicosanoid (leukotriene/TxA2) binding pocket; explains anti‑inflammatory/anti‑platelet activity | Structural comparison, ITC, platelet inhibition assays | Structural basis supporting long-form D7 scavenging of eicosanoids — mechanistic model relevant to D7L2 |
| Martin‑Martin 2021, FEBS J (https://doi.org/10.1111/febs.15524) (martin‐martin2021biochemicalcharacterizationof pages 1-2) | Aedes aegypti — AeD7L2 (long-form) | AeD7L2 binds U-46619 (TXA2 analog), reverses vasoconstriction and inhibits platelet aggregation | ITC, pressure myography, platelet aggregation assays | Demonstrates long-form D7 biochemical activities (eicosanoid/biogenic-amine binding) informative by analogy for AngaD7L2 |
| Martin‑Martin 2020, Nature Communications (https://doi.org/10.1038/s41467-020-16665-z) (martinmartin2020adpbindingby pages 1-2) | Culex quinquefasciatus — CxD7L1/CxD7L2 | Discovery of an ADP/ATP-binding D7 (CxD7L1) with crystal structure; shows functional diversification within D7 family | ITC, X-ray crystallography, platelet assays | Illustrates evolutionary/functional plasticity of D7 long forms and warns against assuming identical ligand specificity for D7L2 |
| Omoke 2024, BMC Genomics (https://doi.org/10.1186/s12864-024-10182-9) | Anopheles arabiensis — D7L1 / D7L2 (orthologs) | Overexpression of D7 long/short genes observed in insecticide-resistant mosquito populations | RNA-Seq transcriptomics combined with insecticide bioassays | Suggests altered D7 expression may associate with insecticide-resistance contexts (possible co-regulation or pleiotropy) |
| Dyer 2024, Proc. R. Soc. B (https://doi.org/10.1098/rspb.2024.1142) | Anopheles gambiae — D7 family (includes D7L2) | Allele-specific expression (ASE) reveals cis-regulatory variation affecting D7 gene expression | RNA-seq of crosses and ASE analysis | Mechanistic insight into regulatory variation controlling D7L2 expression and potential evolutionary selection on regulatory elements |
| Mans 2007, J. Biol. Chem. (https://doi.org/10.1074/jbc.m706410200) | Anopheles gambiae — D7r4 (short-form structure) | Crystal structure defines the D7 fold (eight α-helices, disulfide bonds) and ligand pocket architecture | X-ray crystallography and structural analysis | Provides fold/domain architecture useful for modeling long-form D7L2 domains and predicting ligand-binding pockets |
| Alvarenga 2010, PLoS Biology (https://doi.org/10.1371/journal.pbio.1000547) | Anopheles spp. — long D7 family member | Demonstrated binding of thromboxane A2 analogs and cysteinyl leukotrienes to anopheline long D7 protein with structural/functional characterization | Binding assays and structural work (3D) | Direct evidence that anopheline long D7s bind eicosanoids (TXA2/leukotrienes), supporting expected biochemical role of D7L2 |
Table: Sourced evidence table summarizing key findings, assay types, and relevance of studies that define biochemical function, structure, expression, and applications of D7L2 and related long-form D7 proteins.
References (with links and dates)
- Oseno B et al., Parasites & Vectors, 2022. Characterization of An. gambiae D7 proteins as markers of human–mosquito bite contact. https://doi.org/10.1186/s13071-021-05130-5 (oseno2022characterizationofanopheles pages 1-2)
- Das S et al., BMC Genomics, 2010. Transcriptomic and functional analysis; D7L2 RNAi increases probing time. https://doi.org/10.1186/1471-2164-11-566 (das2010transcriptomicandfunctional pages 9-11)
- Marie A et al., Parasites & Vectors, 2014. P. falciparum infection modulates salivary proteins; long-form D7 overexpressed; antigenic peptides. https://doi.org/10.1186/s13071-014-0599-y (marie2014anophelesgambiaesalivary pages 7-9)
- Jablonka W et al., Scientific Reports, 2019. Structural/functional similarities of long-form D7 proteins; eicosanoid binding pocket. https://doi.org/10.1038/s41598-019-41848-0 (jablonka2019functionalandstructural pages 7-9)
- Martin‑Martin I et al., The FEBS Journal, 2021. Biochemical characterization of AeD7L2; TXA2 analog binding; vascular/platelet effects. https://doi.org/10.1111/febs.15524 (martin‐martin2021biochemicalcharacterizationof pages 1-2)
- Martin‑Martin I et al., Nature Communications, 2020. ADP-binding by a Culex D7L1; structural basis; functional diversification. https://doi.org/10.1038/s41467-020-16665-z (martinmartin2020adpbindingby pages 1-2)
- Dyer N A et al., Proc. R. Soc. B, 2024. Allele-specific expression revealing cis-regulation including D7L2 in An. gambiae. https://doi.org/10.1098/rspb.2024.1142 (oseno2022characterizationofanopheles pages 1-2)
- Omoke D et al., BMC Genomics, 2024. Overexpression of D7L1/D7L2 orthologs in insecticide-resistant An. arabiensis. https://doi.org/10.1186/s12864-024-10182-9 (oseno2022characterizationofanopheles pages 1-2)
Notes on citation scope
- Family-level structural and biochemical inferences are drawn from anopheline D7 long-form studies and closely related dipterans; direct ligand-binding data specific to An. gambiae D7L2 remain to be determined. Where extrapolation is used, it is explicitly qualified. (jablonka2019functionalandstructural pages 7-9, martinmartin2020adpbindingby pages 1-2, martin‐martin2021biochemicalcharacterizationof pages 1-2)
References
(martinmartin2020adpbindingby pages 1-2): Ines Martin-Martin, Andrew Paige, Paola Carolina Valenzuela Leon, Apostolos G. Gittis, Olivia Kern, Brian Bonilla, Andrezza Campos Chagas, Sundar Ganesan, Leticia Barion Smith, David N. Garboczi, and Eric Calvo. Adp binding by the culex quinquefasciatus mosquito d7 salivary protein enhances blood feeding on mammals. Nature Communications, Jun 2020. URL: https://doi.org/10.1038/s41467-020-16665-z, doi:10.1038/s41467-020-16665-z. This article has 36 citations and is from a highest quality peer-reviewed journal.
(jablonka2019functionalandstructural pages 7-9): Willy Jablonka, Il Hwan Kim, Patricia H. Alvarenga, Jesus G. Valenzuela, Jose´ M. C. Ribeiro, and John F. Andersen. Functional and structural similarities of d7 proteins in the independently-evolved salivary secretions of sand flies and mosquitoes. Scientific Reports, Mar 2019. URL: https://doi.org/10.1038/s41598-019-41848-0, doi:10.1038/s41598-019-41848-0. This article has 22 citations and is from a peer-reviewed journal.
(das2010transcriptomicandfunctional pages 9-11): Suchismita Das, Andrea Radtke, Young-Jun Choi, Antonio M Mendes, Jesus G Valenzuela, and George Dimopoulos. Transcriptomic and functional analysis of the anopheles gambiae salivary gland in relation to blood feeding. BMC Genomics, 11:566-566, Oct 2010. URL: https://doi.org/10.1186/1471-2164-11-566, doi:10.1186/1471-2164-11-566. This article has 103 citations and is from a peer-reviewed journal.
(martin‐martin2021biochemicalcharacterizationof pages 1-2): Ines Martin‐Martin, Olivia Kern, Steven Brooks, Leticia Barion Smith, Paola Carolina Valenzuela‐Leon, Brian Bonilla, Hans Ackerman, and Eric Calvo. Biochemical characterization of aed7l2 and its physiological relevance in blood feeding in the dengue mosquito vector, aedes aegypti. The FEBS Journal, 288:2014-2029, Sep 2021. URL: https://doi.org/10.1111/febs.15524, doi:10.1111/febs.15524. This article has 23 citations.
(oseno2022characterizationofanopheles pages 1-2): Brenda Oseno, Faith Marura, Rodney Ogwang, Martha Muturi, James Njunge, Irene Nkumama, Robert Mwakesi, Kennedy Mwai, Martin K. Rono, Ramadhan Mwakubambanya, Faith Osier, and James Tuju. Characterization of anopheles gambiae d7 salivary proteins as markers of human–mosquito bite contact. Parasites & Vectors, Jan 2022. URL: https://doi.org/10.1186/s13071-021-05130-5, doi:10.1186/s13071-021-05130-5. This article has 11 citations and is from a peer-reviewed journal.
(marie2014anophelesgambiaesalivary pages 7-9): Alexandra Marie, Philippe Holzmuller, Majoline T Tchioffo, Marie Rossignol, Edith Demettre, Martial Seveno, Vincent Corbel, Parfait Awono-Ambéné, Isabelle Morlais, Franck Remoue, and Sylvie Cornelie. Anopheles gambiae salivary protein expression modulated by wild plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of an. gambiae bites. Parasites & Vectors, Dec 2014. URL: https://doi.org/10.1186/s13071-014-0599-y, doi:10.1186/s13071-014-0599-y. This article has 24 citations and is from a peer-reviewed journal.
id: A0A1S4GYJ6
gene_symbol: D7L2
product_type: PROTEIN
status: DRAFT
taxon:
id: NCBITaxon:7165
label: Anopheles gambiae
description: >-
D7L2 (AngaD7L2) is a long-form salivary protein from female Anopheles gambiae mosquitoes that
facilitates blood feeding through anticoagulant activity. Unlike the short-form D7 proteins
(D7r1-r4) which primarily bind biogenic amines, D7L2 functions primarily by targeting the
intrinsic coagulation pathway - it binds coagulation factors XII (both inactive and activated
FXIIa) and XI (inactive), preventing generation of activated FXIIa and FXIa. D7L2 also weakly
binds leukotrienes B4 and D4, though this binding is less pronounced than in the related D7L1
protein. The protein belongs to the PBP/GOBP structural family but has evolved a distinct
function unrelated to olfaction.
existing_annotations:
- term:
id: GO:0035821
label: modulation of process of another organism
evidence_type: IEA
original_reference_id: GO_REF:0000108
review:
summary: >-
This annotation correctly describes D7L2's function. The protein modulates host hemostatic
responses during blood feeding by binding coagulation factors XII and XI and preventing
their activation, as well as weakly sequestering leukotrienes. This is a valid BP annotation
for the cross-species effect.
action: ACCEPT
reason: >-
D7L2 clearly modulates processes in the vertebrate host. Per UniProt, it "Modulates blood
feeding of female mosquitoes on vertebrate species by binding and sequestering different
mediators involved in the host response" and "Exhibits anticoagulant activity targeting
the intrinsic coagulation pathway; binds coagulation factors XII and XI, preventing
generation of activated FXIIa and FXIa" [UniProt A0A1S4GYJ6]. The GO:0035821 definition
"A process in which an organism effects a change in a biological process in another organism"
accurately captures this function. PMID:35460690 demonstrates anticoagulant activity through
binding host coagulation factors. The annotation was inferred via GO_REF:0000108 from the
toxin activity annotation, but the underlying logic is sound for this BP term - binding
host coagulation factors does modulate host hemostatic processes.
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Modulates blood feeding of female mosquitoes on vertebrate species by binding and
sequestering different mediators involved in the host response
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds
coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
- term:
id: GO:0005549
label: odorant binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
This annotation is INCORRECT. It is based solely on structural family membership (PBP/GOBP
family via InterPro IPR006170) but does not reflect the actual function of D7L2. The protein
binds coagulation factors and weakly binds leukotrienes, not odorants, and has no role in
olfaction. D7L2 is expressed in salivary glands, not olfactory tissues.
action: REMOVE
reason: >-
D7L2 belongs to the PBP/GOBP structural family (InterPro IPR006170), which led to this
IEA annotation via GO_REF:0000002. However, D7 proteins have evolutionarily repurposed
this fold for binding host hemostatic/inflammatory mediators in saliva, not odorants in
antennae. D7L2 is secreted from female salivary glands during blood feeding [UniProt
A0A1S4GYJ6]. The actual molecular functions involve binding coagulation factors XII and
XI [PMID:35460690, UniProt A0A1S4GYJ6] and weakly binding leukotrienes B4 and D4
[PMID:35460690, UniProt A0A1S4GYJ6]. The GO:0005549 definition "Binding to an odorant, any
substance capable of stimulating the sense of smell" is completely inappropriate - coagulation
factors and leukotrienes are not odorants. This is a clear case where structural homology
does not predict function. Deep research on the D7 family confirms long-form D7s "bind
lipid mediators (cysteinyl leukotrienes; some bind thromboxane A2 analogs) via their
N-terminal domain" [file:ANOGA/D7r1/D7r1-deep-research-falcon.md], not odorants.
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Binds leukotriene B4 and leukotriene D4 (PubMed:35460690). Exhibits anticoagulant
activity targeting the intrinsic coagulation pathway; binds coagulation factors XII
and XI, preventing generation of activated FXIIa and FXIa (PubMed:35460690).
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: "SUBCELLULAR LOCATION: Secreted"
- reference_id: file:ANOGA/D7r1/D7r1-deep-research-falcon.md
supporting_text: >-
long-form D7s bind lipid mediators (cysteinyl leukotrienes; some bind thromboxane A2
analogs) via their N-terminal domain; the biogenic-amine binding role present in the
C-terminal domain of some Aedes long forms appears to be assumed by Anopheles short forms
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
This annotation correctly reflects the subcellular localization of D7L2 as a secreted
salivary protein.
action: ACCEPT
reason: >-
D7L2 is a secreted protein with a signal peptide (residues 1-18) [UniProt A0A1S4GYJ6]. It
is released into the extracellular space (saliva) during blood feeding. The UniProt entry
confirms "SUBCELLULAR LOCATION: Secreted" [UniProt A0A1S4GYJ6]. This is an appropriate CC
annotation. D7L2 functions at the host bite site, which is an extracellular location. Deep
research on the D7 family confirms salivary D7 proteins are "produced in adult female
salivary glands and secreted in saliva at the skin interface during probing/feeding"
[file:ANOGA/D7r1/D7r1-deep-research-falcon.md].
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: "SUBCELLULAR LOCATION: Secreted"
- reference_id: file:ANOGA/D7r1/D7r1-deep-research-falcon.md
supporting_text: >-
D7r1 is produced in adult female salivary glands and secreted in saliva at the skin
interface during probing/feeding
- term:
id: GO:0090729
label: toxin activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
This annotation is an OVER-ANNOTATION. D7L2 does not meet the GO definition of toxin
activity, which requires "initiating pathogenesis (leading to an abnormal, generally
detrimental state)". D7L2 transiently modulates host coagulation by binding coagulation
factors, but does not cause disease or tissue damage. The weak leukotriene binding also
does not constitute toxin activity.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The GO:0090729 definition states: "Interacting selectively with one or more biological
molecules in another (target) organism, initiating pathogenesis (leading to an abnormal,
generally detrimental state) in the target organism." D7L2 does NOT meet this definition
because: (1) It does not initiate pathogenesis - it facilitates feeding, not disease;
(2) It does not cause tissue damage - it transiently binds coagulation factors and weakly
sequesters leukotrienes; (3) The effect is reversible and temporary; (4) The host returns
to normal state after feeding. The UniProt keywords "Blood coagulation cascade inhibiting
toxin" and "Hemostasis impairing toxin" that led to this IEA annotation via GO_REF:0000043
are technically inaccurate - anti-hemostatic activity via protein binding is fundamentally
different from true toxin activity that causes pathological damage. D7L2's mechanism of
binding coagulation factors XII and XI to prevent their activation [PMID:35460690] is a
reversible protein-protein interaction, not toxic pathogenesis. Deep research on D7
proteins explicitly describes the mechanism as kratagonism (scavenging host mediators),
not toxicity [file:ANOGA/D7r1/D7r1-deep-research-falcon.md].
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds
coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
- reference_id: file:ANOGA/D7r1/D7r1-deep-research-falcon.md
supporting_text: >-
D7 proteins are among the most abundant mosquito salivary proteins and function as
kratagonists - high-affinity scavengers of host small-molecule inflammatory and
hemostatic mediators
# PROPOSED NEW ANNOTATIONS
# Note: Being conservative given limited characterization compared to D7L1
- term:
id: GO:0030195
label: negative regulation of blood coagulation
evidence_type: IDA
original_reference_id: PMID:35460690
review:
summary: >-
D7L2 exhibits anticoagulant activity by binding coagulation factors XII and XI and
preventing their activation. This is a well-supported biological process annotation
based on experimental evidence from PMID:35460690.
action: NEW
reason: >-
UniProt states D7L2 "Exhibits anticoagulant activity targeting the intrinsic coagulation
pathway; binds coagulation factors XII and XI, preventing generation of activated FXIIa
and FXIa (PubMed:35460690)" [UniProt A0A1S4GYJ6]. PMID:35460690 demonstrates that
"AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway".
GO:0030195 definition "Any process that stops, prevents, or reduces the frequency, rate
or extent of blood coagulation" accurately describes this function. This is a more accurate
BP annotation than inferring from "toxin activity".
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds
coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35460690
review:
summary: >-
D7L2 binds host coagulation factors XII (both inactive and activated FXIIa) and XI
(inactive). While GO:0005515 is a general term, it accurately describes the molecular
function. This binding underlies D7L2's anticoagulant activity.
action: NEW
reason: >-
UniProt confirms D7L2 "Interacts with host coagulation factor XII/F12 (inactive and
activated) (PubMed:35460690). Interacts with host coagulation factor XI/F11 (inactive)
(PubMed:35460690)" [UniProt A0A1S4GYJ6]. While GO:0005515 is a general MF term, it is
appropriate here because D7L2 binds coagulation factors to prevent their activation -
this is a protein-protein interaction that underlies the anticoagulant activity. There
is no more specific GO term for "coagulation factor binding".
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: Interacts with host coagulation factor XII/F12 (inactive and activated) (PubMed:35460690)
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: Interacts with host coagulation factor XI/F11 (inactive) (PubMed:35460690)
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000044
title: >-
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
mapping, accompanied by conservative changes to GO terms applied by UniProt
findings: []
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on inter-ontology links
findings: []
- id: PMID:35460690
title: >-
Novel salivary antihemostatic activities of long-form D7 proteins from the malaria vector
Anopheles gambiae facilitate hematophagy
findings:
- statement: D7L2 weakly binds leukotrienes B4 and D4
supporting_text: AngaD7L2 weakly binds leukotrienes B4 and D4
- statement: D7L2 has anticoagulant activity targeting the intrinsic pathway
supporting_text: AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway
- statement: D7L2 binds coagulation factors XII, XIIa, and XI
supporting_text: B, kinetic analysis of AngaD7 with FXII (B), FXIIa (C), and FXI (D)
- statement: D7L2 inhibits generation of factors XIIa and XIa
supporting_text: AngaD7L2 inhibits generation of FXIIa and FXIa in normal plasma
- id: UniProt:A0A1S4GYJ6
title: UniProt entry for D7L2_ANOGA
findings:
- statement: D7L2 modulates blood feeding by binding host mediators
supporting_text: >-
Modulates blood feeding of female mosquitoes on vertebrate species by binding and
sequestering different mediators involved in the host response
- statement: D7L2 binds leukotrienes B4 and D4
supporting_text: Binds leukotriene B4 and leukotriene D4
- statement: D7L2 has anticoagulant activity targeting intrinsic pathway
supporting_text: >-
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds
coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
- statement: D7L2 interacts with host coagulation factor XII
supporting_text: Interacts with host coagulation factor XII/F12 (inactive and activated) (PubMed:35460690)
- statement: D7L2 interacts with host coagulation factor XI
supporting_text: Interacts with host coagulation factor XI/F11 (inactive) (PubMed:35460690)
- statement: Protein is secreted
supporting_text: "SUBCELLULAR LOCATION: Secreted"
- id: file:ANOGA/D7r1/D7r1-deep-research-falcon.md
title: Deep research review of D7 protein family function and evolution
findings:
- statement: D7 proteins function as kratagonists that scavenge host signaling molecules
supporting_text: >-
D7 proteins are among the most abundant mosquito salivary proteins and function
as kratagonists - high-affinity scavengers of host small-molecule inflammatory
and hemostatic mediators
- statement: Long-form D7s bind lipid mediators including leukotrienes
supporting_text: >-
long-form D7s bind lipid mediators (cysteinyl leukotrienes; some bind thromboxane A2
analogs) via their N-terminal domain
- statement: D7 proteins are secreted in saliva during feeding
supporting_text: >-
D7r1 is produced in adult female salivary glands and secreted in saliva at the
skin interface during probing/feeding
core_functions:
- description: >-
D7L2 primarily functions as an anticoagulant by binding host coagulation factors XII
(both inactive and activated FXIIa) and XI (inactive), preventing their activation
and thus inhibiting the intrinsic coagulation pathway during blood feeding.
molecular_function:
id: GO:0005515
label: protein binding
directly_involved_in:
- id: GO:0030195
label: negative regulation of blood coagulation
- id: GO:0035821
label: modulation of process of another organism
locations:
- id: GO:0005576
label: extracellular region
supported_by:
- reference_id: UniProt:A0A1S4GYJ6
supporting_text: >-
Exhibits anticoagulant activity targeting the intrinsic coagulation pathway; binds
coagulation factors XII and XI, preventing generation of activated FXIIa and FXIa
- reference_id: PMID:35460690
supporting_text: AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway
suggested_questions:
- question: >-
What are the binding affinities (Kd values) of D7L2 for coagulation factors XII and XI
compared to D7L1? The paper mentions SPR kinetic analysis was performed.
experts:
- Calvo E
- Ribeiro JM
- question: >-
Is the weak leukotriene binding by D7L2 biologically significant, or is D7L1 the primary
leukotriene scavenger among the Anopheles long-form D7 proteins?
experts:
- Calvo E
- Andersen JF
- question: >-
Does D7L2 have any biogenic amine binding activity like the short-form D7 proteins, or
is this function completely absent in Anopheles long-form D7s?
experts:
- Mans BJ
- Calvo E
suggested_experiments:
- hypothesis: >-
D7L2 knockout mosquitoes will have reduced blood feeding efficiency specifically due to
host coagulation responses, while D7L1 knockout effects would be more related to
leukotriene-mediated inflammation
description: >-
Generate individual D7L1 and D7L2 knockout A. gambiae using CRISPR and compare blood
feeding efficiency, clotting time at bite site, and inflammatory responses to determine
the distinct contributions of each long-form D7 protein
experiment_type: Gene knockout and comparative feeding assay
- hypothesis: >-
D7L2 binding to FXII prevents its conformational change required for autoactivation
description: >-
Perform structural studies (X-ray crystallography or cryo-EM) of D7L2 in complex with
FXII and FXIIa to determine the binding interface and mechanism of inhibition
experiment_type: Structural biology